The Tumor Ecosystem: From Bench to Clinic and Back

The Tumor Ecosystem: From Bench to Clinic and Back is organized by Springer Nature and will be held from Nov 19 - 21, 2025 at The University Of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

Description:
This conference aims to provide a forum to present research about: cancer immunology, immunotherapy, cancer metabolism, cancer neuroscience, microbiome, aging, tumor microenvironment, tumor macroenvironment, tumor-host interactions, tumor stroma, systemic effects, metastasis, dormancy, tumor cell dissemination, cancer angiogenesis, and cancer lymphangiogenesis.

This conference will cover the latest advances in understanding the tumor ecosystem and the contributions of its diverse components to how cancer forms and progresses and how it can be diagnosed and treated. We will discuss the dynamic interactions of different tumor, stromal and immune cells and microorganisms in the primary and metastatic tumor microenvironment, but also the interplay of the tumor with its host macroenvironment, including the immune, circulatory and nervous systems and systemic and local metabolism. We will cover how new technologies, including complex cancer model systems, omics approaches and computational science, combined with insights from clinical research are yielding crucial information into response and resistance to therapies for the development of innovative treatment modalities for patients. We will bring together world experts to present the most exciting preclinical, translational and clinical breakthroughs across disciplines and discuss how current knowledge on the tumor ecosystem is being translated from the bench to the patient’s bedside and back to the bench for further research.

This free-to-attend conference will explore recent breakthroughs in understanding the tumor ecosystem and how its various components influence cancer development, progression, diagnosis, and treatment. 

We will explore:

• The intricate relationships among tumor cells, stromal cells, immune cells, and microorganisms in primary and metastatic tumor microenvironments. 
• How tumors interact with host systems, such as the immune, circulatory, and nervous systems, as well as metabolic processes.
• How cutting-edge technologies, including advanced cancer models, omics techniques, computational methods, and clinical research, offer vital insights into therapeutic responses and resistance
• Innovative treatment strategies

We will bring together world experts to present the most exciting preclinical, translational and clinical breakthroughs across disciplines and discuss how current knowledge on the tumor ecosystem is being translated from the bench to the patient’s bedside and back to the bench for further research. Join us for engaging sessions exploring these critical developments shaping the future of cancer treatment, and networking opportunities.